Assessment of Bone Density Following Application of BMAC Around Zygomatic Implant
BMAC
BMAC
Sponsor study identifier
interventional
10
1 country
1
Study Start
June 15, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
April 15, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
June 15, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This prospective case series is designed to evaluate the effect of autologous bone marrow aspirate concentrate applied around zygomatic implants placed via the intrasinus approach. The study will include adult patients with severe maxillary atrophy requiring zygomatic implant rehabilitation. BMAC will be prepared from iliac crest aspirate and loaded on gelatin sponge at the implant site. Peri-implant bone density will be assessed using CBCT at baseline and 6 months postoperatively. Secondary implant stability will be measured using resonance frequency analysis. (Recruitment has not started yet)
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 15, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 15, 2026
Actual (reported)June 15, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 18, 2026
Actual (reported)April 15, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
June 15, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Bone density around zygomatic implants
Bone density measured using Cone Beam Computed Tomography (CBCT) and expressed in Hounsfield Units (HU)
6 months postoperatively
secondary stability of zygomatic implants
6 months postoperatively
All eligible participants with atrophied maxilla receiving zygomatic implant placement for fixed prosthetic rehabilitation.
placement of zygomatic implants via the intrasinus approach in the posterior maxilla of patients with severely atrophied maxilla. Bone marrow aspirate concentrate prepared by double centrifugation of bone marrow aspirated from anterior iliac crest of the patient then loaded on gelatine sponge and applied around the zygomatic implants. Conventional implants may be placed in the anterior maxilla. Procedure performed under general anaesthesia with propofol induction and sevoflurane maintenance.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Faculty of Dentistry, Cairo University , Department of Oral and Maxillofacial Surgery
Cairo, Cairo Governate, 11562, Egypt
Ramy Ragab Elbeialy, Professor of OMFS
Cairo University
First Submitted
June 15, 2026
First Posted
June 18, 2026
Study Start
June 15, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Contact the study team to confirm eligibility.
Primary Completion
April 15, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
June 15, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
June 30, 2026
Record last verified: 2026-06
Individual participant data will not be shared due to ethical restrictions and patient privacy regulations. IPD will be shared after publication.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: